We are live on ! Find out more
MCM

Matarin Capital Management Portfolio holdings

AUM $409M
1-Year Est. Return 33.03%
This Fund
S&P 500
This Quarter Est. Return
-27.18%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
AUM
$644M
AUM Growth
-$402M
Cap. Flow
-$94M
Cap. Flow %
-14.59%
Top 10 Hldgs %
12.69%
Holding
265
New
30
Increased
46
Reduced
108
Closed
67

Sector Composition

1 Financials 16.05%
2 Healthcare 15.51%
3 Technology 15.03%
4 Industrials 13.43%
5 Consumer Discretionary 12.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCOI icon
1
Cogent Communications
CCOI
$560M
$9.92M 1.54%
121,005
-64,937
-35% -$4.91M
INGN icon
2
Inogen
INGN
$178M
$9.29M 1.44%
179,895
+115,145
+178% +$5.53M
MEDP icon
3
Medpace
MEDP
$15.3B
$9.22M 1.43%
125,618
-10,403
-8% -$903K
LRN icon
4
Stride
LRN
$3.67B
$8.72M 1.35%
462,211
+130,401
+39% +$2.41M
AMN icon
5
AMN Healthcare
AMN
$1.36B
$8.28M 1.29%
143,251
+106,406
+289% +$7.28M
KLIC icon
6
Kulicke & Soffa
KLIC
$5.09B
$7.42M 1.15%
355,768
-48,479
-12% -$1.19M
CORT icon
7
Corcept Therapeutics
CORT
$9.69B
$7.42M 1.15%
623,915
-26,360
-4% -$326K
USNA icon
8
Usana Health Sciences
USNA
$407M
$7.34M 1.14%
127,064
-7,208
-5% -$501K
ALRM icon
9
Alarm.com
ALRM
$2.67B
$7.16M 1.11%
184,028
-8,684
-5% -$378K
REGI
10
DELISTED
Renewable Energy Group, Inc.
REGI
$7.01M 1.09%
+341,327
New +$8.64M
SUPN icon
11
Supernus Pharmaceuticals
SUPN
$2.84B
$6.98M 1.08%
387,985
-21,923
-5% -$461K
EVTC icon
12
Evertec
EVTC
$1.87B
$6.93M 1.08%
304,984
-17,293
-5% -$530K
PATK icon
13
Patrick Industries
PATK
$2.96B
$6.75M 1.05%
359,277
+59,005
+20% +$1.88M
INVA icon
14
Innoviva
INVA
$1.63B
$6.65M 1.03%
565,655
-29,333
-5% -$388K
MODV
15
DELISTED
ModivCare
MODV
$6.54M 1.02%
119,259
+17,428
+17% +$1.08M
COKE icon
16
Coca-Cola Consolidated
COKE
$12.2B
$6.27M 0.97%
300,530
-18,140
-6% -$452K
AMKR icon
17
Amkor Technology
AMKR
$15.1B
$6.24M 0.97%
800,754
-45,513
-5% -$495K
ATKR icon
18
Atkore
ATKR
$2.49B
$6.21M 0.96%
294,742
-16,729
-5% -$600K
SHOO icon
19
Steven Madden
SHOO
$3.2B
$6.17M 0.96%
265,630
+5,061
+2% +$175K
PDM
20
Piedmont Realty Trust
PDM
$1.24B
$6.09M 0.95%
345,073
-19,808
-5% -$427K
BHE icon
21
Benchmark Electronics
BHE
$2.76B
$6.01M 0.93%
300,518
-17,229
-5% -$488K
MGLN
22
DELISTED
Magellan Health Services, Inc.
MGLN
$5.99M 0.93%
124,500
+54,652
+78% +$3.51M
WIRE
23
DELISTED
Encore Wire Corp
WIRE
$5.95M 0.92%
141,685
+55,239
+64% +$2.85M
EBS icon
24
Emergent Biosolutions
EBS
$391M
$5.73M 0.89%
+98,970
New +$5.7M
WDR
25
DELISTED
Waddell & Reed Financial, Inc.
WDR
$5.71M 0.89%
502,058
-28,837
-5% -$430K

Similar funds

Matarin Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Matarin Capital Management held 265 positions worth $644M, down 38% from $1.05B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Matarin Capital Management withdrew a net $94M in Q1 2020, closing 67 positions and reducing 108 holdings. Its most notable exit was Arrowhead Research, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Matarin Capital Management opened a new position in Renewable Energy Group, Inc. worth $7.01M.

  • Matarin Capital Management's largest Q1 2020 buy was Renewable Energy Group, Inc.: 341,327 shares worth $7.01M.
  • Matarin Capital Management added most to AMN Healthcare in Q1 2020, an estimated $7.28M increase.
  • Matarin Capital Management's biggest Q1 2020 reduction was Apple, cutting an estimated $10.3M.
  • Matarin Capital Management fully exited Arrowhead Research in Q1 2020, selling an estimated $12.3M.
  • Matarin Capital Management's ten largest holdings make up 13% of its $644M portfolio in Q1 2020.
  • Matarin Capital Management opened 30 new positions and closed 67 in Q1 2020.
  • Matarin Capital Management's portfolio value fell 38% quarter-over-quarter to $644M.

Based on Matarin Capital Management's 13F filing for Q1 2020, filed 27 Apr 2020.